Ovid Therapeutics, Inc. (OVID)

2.95 +0.04 (+1.37%) USD  |  NASDAQ  |  Apr 20, 10:51
More

Ovid Therapeutics Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for OVID.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
PTC Therapeutics, Inc. Upgrade
CytomX Therapeutics, Inc. Upgrade
Artelo Biosciences, Inc. Upgrade
Eton Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade